The virtual webcast, set for 1:30 p.m. ET, serves as a platform for SenesTech to outline its progress in scaling its patented Evolve and ContraPest product lines. These solutions focus on long-term population management through birth control rather than traditional lethal methods, a shift the company argues is more sustainable for integrated pest programs.
In section Releases
SenesTech to Detail Pest Control Strategy at Lytham Investor Summit
Investors will get an inside look at the future of fertility-based rodent management when SenesTech executives take the stage at the Lytham Partners 2026 Consumer & Technology Investor Summit. The presentation, scheduled for August 18, arrives as the company pushes to expand its footprint in both professional and consumer pest markets.
Interested parties can access the live event or subsequent replays via the official Lytham Partners summit portal. Chief Financial Officer Tom Chesterman represents the company, which continues to navigate the complexities of product commercialization and regulatory environments as outlined in its recent SEC filings.
Comments (0)
No comments yet. Be the first!